• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. MERIDIAN FILTER SYSTEM - JUGULAR; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. MERIDIAN FILTER SYSTEM - JUGULAR; VENA CAVA FILTER Back to Search Results
Catalog Number MD800J
Device Problem Occlusion Within Device (1423)
Patient Problem Pulmonary Embolism (1498)
Event Date 03/25/2016
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: as the lot number for the device was not provided, a manufacturing review could not be performed.Medical records review: the patient with a history of morbid obesity and deep venous thrombosis (dvt) had a vena cava filter deployed at the l2-l3 level in satisfactory location and orientation.Approximately four years later, the patient presented to the hospital with chest and abdominal pain.A ct angiogram of chest/abdomen/pelvis revealed multiple right-sided pulmonary emboli, and the filter with clot around it and a large thrombus to the left iliac vein.Additionally, a large retroperitoneal hematoma within the pelvis and layering through the bilateral paracolic gutters was noted; unable to exclude underlying mass or venous source of hemorrhage.No further information is noted regarding the patient¿s current status.Investigation summary: the device was not returned for evaluation and images were not provided for review.However, medical records were provided for review.Approximately four years post filter deployment, a ct angiogram revealed multiple right-sided pulmonary emboli, and ivc filter with clot around it and large thrombus to the left iliac vein.Therefore, based on the medical records, it can be confirmed the patient experienced pe after filter implantation.However, the origin of the pe and relationship to the filter have not been determined in the provided medical records.The investigation is inconclusive for the alleged occlusion within the filter, as the medical records only indicate clot around the filter at time of ct angiogram.Based upon the available information, the definitive root cause is unknown.Labeling review: the current ifu (instructions for use) states: warnings/potential complications: acute or recurrent pulmonary embolism.This has been reported despite filter usage.It is not known if thrombi passed through the filter, or originated from superior or collateral vessels.Caval thrombosis/occlusion.It is possible that complications such as those described in the "warnings", "precautions," or "potential complications" sections of this instructions for use may affect the recoverability of the device and result in the clinician's decision to have the device remain permanently implanted.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in conjunction with or before a bariatric procedure.Some time post filter deployment, the filter was allegedly occluded and the patient experienced a pulmonary embolism.Patient status was not reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MERIDIAN FILTER SYSTEM - JUGULAR
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key7138758
MDR Text Key95512325
Report Number2020394-2017-01786
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K102511
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Attorney
Type of Report Initial
Report Date 12/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMD800J
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/27/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FLEXERIL, MIRAPEX, NYSTATIN, TRAMADOL, TRAZADONE
Patient Outcome(s) Hospitalization; Life Threatening;
Patient Age53 YR
-
-